Clinical Trial: Effects of Early PCSK9 Inhibitor Therapy on Inflammatory Response and Related Adipokines in Patients with Acute Myocardial Infarction (China)

Posted On: 2026-09-28

China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effects of Early PCSK9 Inhibitor Therapy on Inflammatory Response and Related Adipokines in Patients with Acute Myocardial Infarction'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133435

Registration Time: 2026/09/28

Type: Interventional study

Primary Sponsor: Liuzhou Worker's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335592

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Effects of Early PCSK9 Inhibitor Therapy on Inflammatory Response and Related Adipokines in Patients with Acute Myocardial Infarction (China)